Prospects for immunotherapy of MHC class I-deficient tumours
Bubeník, J.
Folia Biologica 49(3): 95-99
2003
ISSN/ISBN: 0015-5500 PMID: 12859017 Document Number: 558814
Document emailed within 1 workday
Related Documents
Indrová, M.; Bieblová, J.; Jandlová, T.án.; Vonka, V.ír.; Pajtasz-Piasecka, E.; Reinis, M. 2006: Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours International Journal of Oncology 28(1): 253-259Scott, M.T. 1977: Chemo-immunotherapy of mouse tumours using cyclophosphamide and C. parvum Developments in Biological Standardization 38: 307-310
Kara, C.J.; Glimcher, L.H. 1993: Promoter accessibility within the environment of the MHC is affected in class II-deficient combined immunodeficiency EMBO Journal 12(1): 187-193
Hwang, C.; Sanda, M.G. 1999: Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy Current Opinion in Molecular Therapeutics 1(4): 471-479
Lehmann-Grube, F.; Dralle, H.; Utermöhlen, O.; Löhler, J. 1994: MHC class I molecule-restricted presentation of viral antigen in beta 2-microglobulin-deficient mice Journal of Immunology 153(2): 595-603
Stanislavskiĭ, E.S.; Joó, I. 1983: Immunoprophylaxis and immunotherapy of infection caused by Pseudomonas aeruginosa: research results and prospects Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1983(7): 22-31
Fu, F.; Li, Y.; Qian, S.; Lu, L.; Chambers, F.; Starzl, T.E.; Fung, J.J.; Thomson, A.W. 1996: Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients Transplantation 62(5): 659-665
Anisimov, V.N.; Nikonov, A.A. 1990: Pathology of tumours in laboratory animals. Tumours of the rat. Tumours of the vagina, uterus and oviduct Iarc Scientific Publications 99: 445-471
Ito, N.; Shirai, T. 1990: Pathology of tumours in laboratory animals. Tumours of the rat. Tumours of the accessory male sex organs Iarc Scientific Publications 99: 421-443
Elwell, M.R.; Boorman, G.A. 1990: Pathology of tumours in laboratory animals. Tumours of the rat. Tumours of the Harderian gland Iarc Scientific Publications 99: 79-87
Meitert, E.; Meitert, T. 1983: Possibilities and prospects of immunoprophylaxis and immunotherapy of pyocyanic infections under supervision of these infections using epidemiological markers Revista de Igiena Bacteriologie Virusologie Parazitologie Epidemiologie Pneumoftiziologie. Pneumoftiziologia 32(4): 289-302
Hayes, B.K.; Esquivel, F.; Bennink, J.R.; Yewdell, J.W.; Varki, A. 1995: Structure of the N-linked oligosaccharides of MHC class I molecules from cells deficient in the antigenic peptide transporter. Implications for the site of peptide association Journal of Immunology 155(8): 3780-3787
Longnecker, D.S.; Millar, P.M. 1990: Pathology of tumours in laboratory animals. Tumours of the rat. Tumours of the pancreas Iarc Scientific Publications 99: 241-257
Maekawa, A. 1990: Pathology of tumours in laboratory animals. Tumours of the rat. Tumours of the ovary Iarc Scientific Publications 99: 473-497
Mostofi, F.K.; Sesterhenn, I.A.; Bresler, V.M. 1990: Pathology of tumours in laboratory animals. Tumours of the rat. Tumours of the testis Iarc Scientific Publications 99: 399-419
Gil, M.L.; Vita, N.; Lebel-Binay, S.; Miloux, B.; Chalon, P.; Kaghad, M.; Marchiol-Fournigault, C.; Conjeaud, H.; Caput, D.; Ferrara, P. 1992: A member of the tetra spans transmembrane protein superfamily is recognized by a monoclonal antibody raised against an HLA class I-deficient, lymphokine-activated killer-susceptible, B lymphocyte line. Cloning and preliminary functional studies Journal of Immunology 148(9): 2826-2833
Leibnitz, R.R.; Lipsky, P.E.; Thiele, D.L. 1995: Protection from T helper cell-mediated graft-versus-host disease by the presence of an MHC class I alloantigen is associated with perturbation of MHC class II-restricted responses by class I-derived peptides Journal of Immunology 155(4): 1784-1795
Udaka, K.; Marusić-Galesić, S.; Walden, P. 1994: CD4+ and CD8+ alpha beta, and gamma delta T cells are cytotoxic effector cells of beta 2-microglobulin-deficient mice against cells having normal MHC class i expression Journal of Immunology 153(6): 2843-2850
Halimi, A.; Azeroual, M.F.; Abouqal, R.; Zaoui, F. 2011: A comparative study of the transverse dimensions of the dental arches between Class i dental occlusion and Class II1 and Class II2 malocclusions Odonto-Stomatologie Tropicale 34(136): 47-52
Manzotti, G.; Riario-Sforza, G.G.; Dimatteo, M.; Scolari, C.; Makri, E.; Incorvaia, C. 2016: Comparing the compliance to a short schedule of subcutaneous immunotherapy and to sublingual immunotherapy during three years of treatment European Annals of Allergy and Clinical Immunology 48(6): 224-227